Assessment of synthetic peptides of severe acute respiratory syndrome coronavirus recognized by long-lasting immunity

Tissue Antigens

Volumn 64, Issue 5, 2004, Pages 600-607

  Shichijo, S ^a   Keicho, N ^b   Long, H T ^c   Quy, T ^d   Phi, N C ^d   Ha, L D ^d   Ban, V V ^e   Itoyama, S ^b   Hu, C J ^f   Komatsu, N ^a   Kirikae, T ^b   Kirikae, F ^b   Shirasawa, S ^b   Kaji, M ^g   Fukuda, T ^g   Sata, M ^a   Kuratsuji, T ^b   Itoh, K ^a   Sasazuki, T ^b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c National Institute of Hygiene and Epidemiology   (Viet Nam)

^d BACH MAI HOSPITAL   (Viet Nam)

^e Hanoi French Hospital   (Viet Nam)

^f JEN AI HOSPITAL   (Taiwan)

^g KURUME UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

IgG; Long lasting immunity; SARS; Structural protein; Synthetic peptides

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G; PEPTIDE M101; PEPTIDE M121; PEPTIDE M141; PEPTIDE M151; PEPTIDE M171; PEPTIDE M181; PEPTIDE M207; PEPTIDE N161; PEPTIDE N181; PEPTIDE N221; PEPTIDE N231; PEPTIDE N241; PEPTIDE N271; PEPTIDE N281; PEPTIDE N291; PEPTIDE N301; PEPTIDE N321; PEPTIDE N331; PEPTIDE S151; PEPTIDE S181; PEPTIDE S191; PEPTIDE S381; PEPTIDE S791; PEPTIDE S811; SARS CORONAVIRUS PROTEIN; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS PROTEIN;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; SARS CORONAVIRUS;

ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNE SYSTEM; IMMUNITY; IMMUNOGLOBULIN G; PEPTIDES; RHEOLOGY; SARS VIRUS; SERUM;

CORONAVIRUS; RNA VIRUSES; SARS CORONAVIRUS;

EID: 8144221377     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2004.00314.x     Document Type: Article

References (17)

1. Drosten C, Gunther S, Preiser W et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003: 348: 1967-76.
2. Ksiazek TG, Erdman D, Goldsmith CS et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003: 348: 1953-66.
3. Rota PA, Oberste MS, Monroe SS et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003: 300: 1394-9.
4. Wang J, Wen J, Li J et al. Assessment of immunoreactive synthetic peptides from the structural proteins of severe acute respiratory syndrome coronavirus. Clin Chem 2003: 49: 1989-96.
5. Cavanagh D. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus. Avian Pathol 2003: 32: 567-82.
6. Gao W, Tamin A, Soloff A et al. Effects of a SARS-associated coronavirus vaccine in monkeys. Lancet 2003: 362: 1895-6.
7. Li W, Moore MJ, Vasilieva N et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003: 426: 450-4.
8. He L, Ding YQ, Che XY et al. Expression of the monoclonal antibody against nucleocapsid antigen of SARS-associated coronavirus in autopsy tissues from SARS patients. Di Yi Jun Yi Da Xue Xue Bao 2003: 23: 1128-30.
9. Komatsu N, Shichijo S, Nakagawa M, Itoh K. New multiplexed flow cytometric assay to measure anti-peptide antibody: a novel tool for monitoring immune responses to peptides used for immunization. Scand J Clin Lab Invest 2004: 64: 535-546.
10. Wang YS, Shen H, Sun SH et al. Analysis of false-positive associated with antibody tests for SARS-CoV in SLE patients. Shi Yan Sheng Wu Xue Bao 2003: 36: 314-7.
11. Pearson H. Antibodies to SARS-like virus hint at repeated infections. Nature 2004: 427: 185.
12. Zhuang JH, Huang XZ, Zhou Q, Lin LY, Lin L. Dynamic observation IgG and IgM antibodies in patients with severe acute respiratory syndrome. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2003: 15: 579-81.
13. Hsueh PR, Hsiao CH, Yeh SH et al. Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan. Emerg Infect Dis 2003: 9: 1163-7.
14. Wang HB, Liu JH, Ouyang XL et al. Detection of the anti-SARS coronavirus-specific antibody levels in 156 SARS patients. Zhongguo Shi Van Xue Ye Xue Za Zhi 2003: 11: 441-3.
15. Gordon RF, McDade RL. Multiplexed quantification of human IgG, IgA, and IgM with the FlowMetrix™ system. Clin Chem 1997: 43: 1799-801.
16. WHO. Severe acute respiratory syndrome (SARS). Wkly Epidemiol Rec 2003: 78: 81-3.
17. Kawamoto N, Yamada A, Ohkouchi S et al. IgG reactive to CTL-directed epitopes of self-antigens is either lacking or unbalanced in atopic dermatitis patients. Tissue Antigens 2003: 61: 1-10.